Prosecution Insights
Last updated: August 18, 2026

Keygene N V

12 pending office actions • 8 art units • 12 examiners • 0 of 12 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days

Portfolio Summary

12
Total Pending OAs
8
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (42%)
6
Medium (50%)
1
Easy (8%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only5 (42%)
§112 only1 (8%)
Double-patenting + other1 (8%)
Multi-statute (no §101)5 (42%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

10
Life Sciences
83% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
2
Business / Other
17% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

120 h
Manual time on pending OAs
24 h
Time saved (low, 20%)
42 h
Time saved (mid, 35%)
1.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KEOGH, MATTHEW R 1 78.3% +14.5%
SHEN, YANXIN NMN 1 83.3% +27.8%
ZHENG, LI 1 83.6% +12.8%
WILLIAMS, KEITH RICHARD 1 41.7% +0.0%
STOCKDALE, JESSICA NICOLE 1 45.2% +41.5%
MEYER, GEORGE WILLIAM 1 100.0% +0.0%
TURPIN, ZACHARY MARK 1 4.8% -5.9%
LAFAVE, ELIZABETH ROSE 1 58.3% +46.6%
BAKSHI, PANCHAM 1 77.0% +30.2%
LU, FRANK WEI MIN 1 62.6% +67.6%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19135838 REGENERATION BY PROTOPLAST CALLUS GRAFTING SHEN, YANXIN NMN
19209115 METHOD FOR TARGETED ALTERATION OF DUPLEX DNA ZHENG, LI

Hard Cases (6)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17837904 SEMI-SOLID STATE NUCLEIC ACID MANIPULATION BAKSHI, PANCHAM 16d overdue
17297859 TARGETED ENRICHMENT BY ENDONUCLEASE PROTECTION LU, FRANK WEI MIN 8d overdue
19106659 HYDROGEL-CARRIERS FOR INDUCTION OF PLANT MORPHOGENESIS WILLIAMS, KEITH RICHARD
18487029 CO-REGENERATION RECALCITRANT PLANTS STOCKDALE, JESSICA NICOLE
18487025 MOBILE ENDONUCLEASES FOR HERITABLE MUTATIONS MEYER, GEORGE WILLIAM
18038381 Targeted enrichment using nanopore selective sequencing TURPIN, ZACHARY MARK

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
17843612 NGS LIBRARY PREPARATION USING COVALENTLY CLOSED NUCLEIC ACID MOLECULE ENDS LAFAVE, ELIZABETH ROSE 43d overdue
17837904 SEMI-SOLID STATE NUCLEIC ACID MANIPULATION BAKSHI, PANCHAM 16d overdue
17297859 TARGETED ENRICHMENT BY ENDONUCLEASE PROTECTION LU, FRANK WEI MIN 8d overdue
19296788 SHOOT REGENERATION BY OVEREXPRESSION OF CHK GENES KEOGH, MATTHEW R
19135838 REGENERATION BY PROTOPLAST CALLUS GRAFTING SHEN, YANXIN NMN
19209115 METHOD FOR TARGETED ALTERATION OF DUPLEX DNA ZHENG, LI
18487029 CO-REGENERATION RECALCITRANT PLANTS STOCKDALE, JESSICA NICOLE

Top Art Units

Art UnitApps
1663 3
1662 1
1637 1
1682 1
1684 1
1623 1
1683 1
1681 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19296788 SHOOT REGENERATION BY OVEREXPRESSION OF CHK GENES KEOGH, MATTHEW R §103 Non-Final OA Pending Aug 11, 2025
19135838 REGENERATION BY PROTOPLAST CALLUS GRAFTING SHEN, YANXIN NMN 1663 §112 Non-Final OA Pending Jun 05, 2025
19209115 METHOD FOR TARGETED ALTERATION OF DUPLEX DNA ZHENG, LI 1662 §103 Non-Final OA Pending May 15, 2025
19106659 HYDROGEL-CARRIERS FOR INDUCTION OF PLANT MORPHOGENESIS WILLIAMS, KEITH RICHARD §103§112 Non-Final OA Pending Feb 26, 2025
18487029 CO-REGENERATION RECALCITRANT PLANTS STOCKDALE, JESSICA NICOLE 1663 §102§103 Final Rejection Pending Oct 13, 2023
18487025 MOBILE ENDONUCLEASES FOR HERITABLE MUTATIONS MEYER, GEORGE WILLIAM 1637 §103§112 Non-Final OA Pending Oct 13, 2023
18038381 Targeted enrichment using nanopore selective sequencing TURPIN, ZACHARY MARK 1682 §112DP Final Rejection Pending May 23, 2023
17843612 NGS LIBRARY PREPARATION USING COVALENTLY CLOSED NUCLEIC ACID MOLECULE ENDS LAFAVE, ELIZABETH ROSE 1684 §103 Non-Final OA 43d overdue Pending Jun 17, 2022
17837904 SEMI-SOLID STATE NUCLEIC ACID MANIPULATION BAKSHI, PANCHAM 1623 §102§103§112 Non-Final OA 16d overdue Pending Jun 10, 2022
17297859 TARGETED ENRICHMENT BY ENDONUCLEASE PROTECTION LU, FRANK WEI MIN 1683 §102§103 Final Rejection 8d overdue Pending May 27, 2021
17118429 NUCLEIC ACID AMPLIFICATION METHOD YU, TIAN NMN 1681 §103 Final Rejection Pending Dec 10, 2020
17081832 GENES FOR HORMONE-FREE PLANT REGENERATION BOGGS, RUSSELL T 1663 §103 Non-Final OA Pending Oct 27, 2020

Managing Keygene N V's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month